Develop Business in Global Market, Sido Muncul Open Branch in Philippines and Nigeria

By : Hariyanto And Aldi Firhand. A | Tuesday, April 03 2018 - 21:26 IWST

PT Industri Jamu dan Farmasi Sido Muncul Tbk (SIDO)
PT Industri Jamu dan Farmasi Sido Muncul Tbk (SIDO)

INDUSTRY.co.id - Jakarta - PT Industri Jamu dan Farmasi Sido Muncul Tbk (SIDO) is increasingly aggressively expanding its business in the global market by opening branches in the Philippines and Nigeria.

"We are still exploring to many countries by expanding the marketing area," said Director of PT Jamu and Sido Megah Industries Irwan Hidayat to press in Jakarta, Tuesday (3/4/2018).

Currently, the progress of market expansion to destination countries is still in the process of obtaining permits. "So we are still doing registration at POM (Food Drug Control) in the country there," said Irwan.

He said, in developing the market, Sido Muncul more prioritize the marketing office in many countries, not making factories abroad.

"The business scheme is more efficient and effective for this company. We are looking for distributors there, and for the marketing office, there is no need for the factory there, from Indonesia just send it," said Irwan.

Previously, Finance Director of PT Industri Jamu dan Farmasi Sido Muncul Tbk Venancia Sri Indrijati Wijono said that the export portion of SIDO's revenue is still very small at 1%. However, less than two years, Herbal and Pharmaceutical Industry Sido Muncul targets the export portion can reach 5%.

Given the financial statements of the third quarter-2017, Jamu and Pharmaceutical Industry Sido Muncul recorded net sales of Rp1, 86 trillion. This achievement decreased 1.79% compared to the sales of third quarter-2016 of Rp 1.89 trillion.

The details of the sale of PT Industri Jamu dan Farmasi Sido Muncul Tbk appeared in the third quarter of 2017, for herbal medicine and supplement products amounting to Rp 1.19 trillion or up 7.5% year on year (yoy). Food and beverage products decreased 17.12% to Rp 599.89 billion, while pharmaceutical revenues amounted to Rp 68.53 billion, up 11.55% yoy. (imq)

News Comment

Today's Industry

Ponemon Institute

Selasa, 16 April 2019 - 11:16 WIB

2019 Ponemon Study on Automation and Cybersecurity Staffing in Asia Pacific, United States and the UK shows an evolving Asia Pacific cybersecurity arena

2019 Ponemon Study on Automation and Cybersecurity Staffing in Asia Pacific, United States and the UK shows an evolving Asia Pacific cybersecurity arena

Hypertherm software

Selasa, 16 April 2019 - 10:57 WIB

Hypertherm Unveils New Home for Cam Software Content

Hypertherm unveils new home for CAM software content HANOVER, N.H. — April 16, 2019 — Hypertherm, a U.S. based manufacturer of industrial cutting systems and software, is unveiling a brand-new…

Etihad Airways airline (Foto Ist)

Kamis, 11 April 2019 - 12:44 WIB

ETIHAD AIRWAYS TO INTRODUCE BOEING 787 ON SERVICES TO KUALA LUMPUR AND BRUSSELS

ETIHAD AIRWAYS TO INTRODUCE BOEING 787 ON SERVICES TO KUALA LUMPUR AND BRUSSELS

Synopsys Recognized as a Leader in Independent Analyst Report on Software Composition Analysis Solutions

Kamis, 11 April 2019 - 12:34 WIB

Synopsys Recognized as a Leader in Independent Analyst Report on Software Composition Analysis Solutions

Synopsys Recognized as a Leader in Independent Analyst Report on Software Composition Analysis Solutions

Grab (Ist)

Kamis, 11 Oktober 2018 - 12:36 WIB

Women Activists Criticize GRAB Indonesia on Victims Harassment Mediation

A number of women activists express their anger and regret at the GRAB Indonesia. The Malaysian applicator response to bring together between a driver partner who is allegedly harassed his passengers…